Jane Street Group, LLC Applied Genetic Technologies Corp Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.62 - $1.1 $8,020 - $14,229	-12,936 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.07 - $2.71 $410 - $1,040	-384 Reduced 2.88%	12,936 $14,000
Q4 2021 Feb 15, 2022	SELL	$1.87 - $2.91 $2,221 - $3,457	-1,188 Reduced 8.19%	13,320 $25,000
Q3 2021 Nov 16, 2021	SELL	$3.01 - $4.12 $73,648 - $100,808	-24,468 Reduced 62.78%	14,508 $44,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $124,278 - $179,551	-34,331 Reduced 46.83%	38,976 $152,000
Q1 2021 May 18, 2021	BUY	$3.94 - $8.19 $288,829 - $600,384	73,307 New	73,307 $371,000
Q3 2020 Nov 17, 2020	SELL	$4.38 - $6.43 $92,159 - $135,293	-21,041 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$3.0 - $6.9 $63,123 - $145,182	21,041 New	21,041 $117,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.